EE552 Importance of Half Cycle Correction for Cost-Effectiveness Analysis: Case Study of Sacubitril/Valsartan Vs in Enalapril Heart Failure with Reduced Ejection Fraction
For products indicated for chronic heart failure with reduced ejective fraction (HFrEF) half-cycle correction might be of increased importance to capture effect of survival gains and reduction in hospitalizations. To understand the importance and effect of half-cycle correction in cost-effectiveness analysis for Sacubitril/Valsartan vs Enalapril in HFrEF.
Source: Value in Health - Category: International Medicine & Public Health Authors: S. Aggarwal, S. Kumar, O. Topaloglu Source Type: research
More News: Cardiology | Diovan | Enalapril | Heart | Heart Failure | International Medicine & Public Health | Study